Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has conducted its 5th board meeting for FY2024, where they approved a significant capital injection into Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. The board, in full attendance, also sanctioned a resultant joint venture and a substantial guarantee provision, both contingent on the completion of the capital injection and classified as interested person transactions.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
